Truven to sell $40 million tap of 10 5/8% notes due 2020 on Thursday

By Paul A. Harris

Portland, Ore., Nov. 6 – Truven Health Analytics Inc. plans to price a $40 million add-on to its 10 5/8% senior notes due 2020 (existing ratings Caa2/CCC+) on Thursday trailing a late-morning conference call with investors, according to a market source.

J.P. Morgan Securities LLC is the bookrunner for the Rule 144A and Regulation S with registration rights offering.

Proceeds, together with cash on hand, will be used to finance the acquisition of Heartbeat Experts, a provider of stakeholder information essential for life sciences companies to gain drug approval, reimbursement and adoption. Proceeds will also be used to repay revolver debt drawn to finance the acquisition of Joan Wellman and Associates, Inc., a provider of consulting services to the health care industry.

Truven is an Ann Arbor, Mich.-based provider of information, analytic tools, benchmarks, services, and related expertise to the health care industry.

The add-on notes will be issued under the indenture dated June 6, 2012 governing the $327,150,000 of 10 5/8% senior notes due 2020 issued on that date.

The add-on notes will form a single series with the existing notes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.